$GYHT HALOZYME THERAPEUTICS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in HALOZYME THERAPEUTICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in HALOZYME THERAPEUTICS, INC. for free.
IRS Number: 880488686
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: GYHT
Company Address: 11388 SORRENTO VALLEY ROAD SAN DIEGO 92121-1345
Former name: GLOBAL YACHT SERVICES INC, date of change: 2001-09-12
Former name: HALOZYME THERAPEUTICS INC, date of change: 2004-03-12
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
HALOZYME THERAPEUTICS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 400,000 | |
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 39.66 | 50,000 | 1,982,950 | 537,160 | 587.2 K to 537.2 K (-8.52 %) |
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 5,230 | 0 | 128,983 | 123.8 K to 129 K (+4.23 %) |
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Grant | A | 0.00 | 5,230 | 0 | 213,983 | 208.8 K to 214 K (+2.51 %) |
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Henderson Jeffrey William | Director | Grant | A | 0.00 | 5,230 | 0 | 52,839 | 47.6 K to 52.8 K (+10.99 %) |
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Daly James M | Director | Grant | A | 0.00 | 5,230 | 0 | 26,232 | 21 K to 26.2 K (+24.90 %) |
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Connaughton Bernadette | Director | Grant | A | 0.00 | 5,230 | 0 | 32,013 | 26.8 K to 32 K (+19.53 %) |
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | BIZZARI JEAN-PIERRE | Director | Grant | A | 0.00 | 5,230 | 0 | 87,544 | 82.3 K to 87.5 K (+6.35 %) |
| May 03 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 11.29 | 11,311 | 127,701 | 0 | |
| May 03 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 11.29 | 11,311 | 127,701 | 134,111 | 122.8 K to 134.1 K (+9.21 %) |
| Apr 14 2021 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 45.00 | 5,000 | 225,000 | 179,833 | 184.8 K to 179.8 K (-2.71 %) |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 500,000 | |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 42.55 | 50,000 | 2,127,250 | 537,160 | 587.2 K to 537.2 K (-8.52 %) |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |